Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine.

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

Flickstree creates and aggregates short engaging videos. Publishers (websites and apps) embed Flickstree's video player on their platform, to engage and monetize their traffic, without any investment on part of any Publisher. Videos include entertainment content, performance marketing content and user-generated content. These are all localized in multiple languages. OTT platforms and telecom companies license these videos too. Entertainment videos are monetised through branding campaigns - pre roll and mid roll video ads. Brands use Flickstree's 50Mn+ reach to create Impact at scale and force-multiply their campaign goals. Flickstree's "Glocal" publisher network acts as a huge catalyst to achieve brand objectives. Performance marketing videos are monetized through Cost Per Sale (CPS) campaigns - best in industry affiliate commission, achieved on the sale of products across various categories. Flickstree is backed by Samsung Ventures Investment, SOSV, LionRock Capital, Accretio Investment, Facebook FBStart program and the star cricketer Sourav Ganguly, amongst others.

ScaleHub, a Managed Service Hub for AI data labeling and data processing best practices delivers super-human quality data - at scale. ScaleHub's solution is HIPAA compliant, ISO 27001:2013 certified and GdPR compliant.

Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise, and deep technology to develop delicious, nutritious, affordable, and sustainable non-GMO plant-based ingredients – from the ground up. For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of the projected demand for plant-based foods. What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogs more delicious, nutritious, cost-effective, and sustainable. The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience which are critical to ensure food security in light of climate change. Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.

Founded in August 2020, the Sybill team is composed of folks from Stanford, MIT, and various IITs. We are building the superhuman AI engine to solve the next big problem in video conferencing: How to understand and engage better with humans in remote video calls. Put simply, Sybill helps you read minds. The engine acts as the speaker’s extra set of eyes and ears on video calls to provide real-time insights around attendees' level of agreement and engagement throughout a meeting. Targeted at sales teams who have shifted to virtual selling, Sybill offers the seller the type of "feel" and insight they could only get before by traveling to a customer for in-person meetings. This superhuman ability to read the virtual room will help sales continue to drive more sales engagements virtually, and help reduce traditionally high travel and expense costs.

Ascertain is a revolutionary new partnership between Northwell Health, New York’s largest healthcare provider, and Aegis Ventures, a dynamic startup studio. This unique partnership assembles leading medical, technology, and business resources to create a first-of-its-kind company creation platform for healthcare innovation to address healthcare’s most challenging quality, equity, and cost problems. Ascertain creates companies that improve quality of care, patient experience, and long-standing health, placing patient needs at the center of every business model, technology solution, and product.

Blooma delivers a faster and more intelligent commercial real estate lending experience through the use of a unique digital underwriting platform driven by artificial intelligence and machine learning. Blooma's AI platform helps lenders reduce loan origination time and cost and perform a more comprehensive analysis of their transactions.